Burden of Respiratory Syncytial Virus Infection in Immunocompromised Adults: A Systematic Review of the Evidence From High-Income Countries

Individuals with immunocompromising conditions or receiving immunosuppressive therapy are at increased risk for severe outcomes and complications from respiratory syncytial virus (RSV). An in-depth systematic investigation into severe RSV disease among immunocompromised adults is lacking. We therefore performed this systematic literature review to summarize the literature (2000-2024) on the burden of RSV disease across a broad spectrum of immunocompromising conditions in adults residing in high-income countries, in terms of the incidence of RSV infection and the prevalence of hospitalizations, complications, and mortality among RSV-infected individuals. Relevant English-language articles were retrieved through PubMed and Embase searches. We included 36 articles in our review. All but four studies were conducted in Europe or the USA. Most evaluated solid organ transplant recipients (n = 11, including 8 evaluating lung transplants) or hematopoietic stem cell transplant recipients (n = 17). Our review shows that, in most studies, substantial proportions of RSV-infected immunocompromised adults required hospitalization (37.5-87.5% in lung transplant, 37.7-68.0% in any solid organ transplant, and 30.3-83.9% in stem cell transplant recipients), intensive care unit admission (11.7% in lung, 3.9-17.9% in any solid organ, and 4.8-29.8% in stem cell transplant recipients), and mechanical ventilation (0.0-10.4% in lung, 3.9-14.3% in any solid organ, and 2.7-29.8% in stem cell transplant recipients). Data from the identified articles indicate that in solid organ (especially lung) and stem cell transplant patients, the degree of immunosuppression-determined by anti-rejection regimens, corticosteroid dosing, and other adjunctive agents-may be an important determinant of the risk of RSV. Our review confirms that RSV poses a significant burden on immunocompromised adults, emphasizing the need to implement preventive strategies such as vaccination in this population.

Authors

Institutions

Publication Details

Journal
Infectious Diseases and Therapy
Published
2026-06-30
DOI
https://doi.org/10.1007/s40121-026-01379-4
Primary Topic
Respiratory viral infections research
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Burden of Respiratory Syncytial Virus Infection in Immunocompromised Adults: A Systematic Review of the Evidence From High-Income Countries

Jeffrey R. Curtis, Michael D. Nissen, Yolanda Penders, Veronica Hulstrøm et al.
Infectious Diseases and Therapy
Respiratory viral infections research
article

Burden of Respiratory Syncytial Virus Infection in Immunocompromised Adults: A Systematic Review of the Evidence From High-Income Countries

Jeffrey R. Curtis, Michael D. Nissen, Yolanda Penders, Veronica Hulstrøm, Kemi Oluwayi, Pouya Saeedi, Bela Vatsa, Jean-Yves Pirçon
article en

Abstract

Individuals with immunocompromising conditions or receiving immunosuppressive therapy are at increased risk for severe outcomes and complications from respiratory syncytial virus (RSV). An in-depth systematic investigation into severe RSV disease among immunocompromised adults is lacking. We therefore performed this systematic literature review to summarize the literature (2000-2024) on the burden of RSV disease across a broad spectrum of immunocompromising conditions in adults residing in high-income countries, in terms of the incidence of RSV infection and the prevalence of hospitalizations, complications, and mortality among RSV-infected individuals. Relevant English-language articles were retrieved through PubMed and Embase searches. We included 36 articles in our review. All but four studies were conducted in Europe or the USA. Most evaluated solid organ transplant recipients (n = 11, including 8 evaluating lung transplants) or hematopoietic stem cell transplant recipients (n = 17). Our review shows that, in most studies, substantial proportions of RSV-infected immunocompromised adults required hospitalization (37.5-87.5% in lung transplant, 37.7-68.0% in any solid organ transplant, and 30.3-83.9% in stem cell transplant recipients), intensive care unit admission (11.7% in lung, 3.9-17.9% in any solid organ, and 4.8-29.8% in stem cell transplant recipients), and mechanical ventilation (0.0-10.4% in lung, 3.9-14.3% in any solid organ, and 2.7-29.8% in stem cell transplant recipients). Data from the identified articles indicate that in solid organ (especially lung) and stem cell transplant patients, the degree of immunosuppression-determined by anti-rejection regimens, corticosteroid dosing, and other adjunctive agents-may be an important determinant of the risk of RSV. Our review confirms that RSV poses a significant burden on immunocompromised adults, emphasizing the need to implement preventive strategies such as vaccination in this population.

Infectious Diseases and Therapy
The University of Queensland (AU), University of Alabama at Birmingham (US), GlaxoSmithKline (Belgium) (BE), Prince Charles Hospital (AU)
Openalex Percentile: Top 8%
Respiratory viral infections research
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.